Edition:
United States

Admedus Ltd (AHZ.AX)

AHZ.AX on Australia Stock Exchange

0.37AUD
20 Jan 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.37
Open
$0.38
Day's High
$0.38
Day's Low
$0.37
Volume
61,280
Avg. Vol
1,366,238
52-wk High
$0.68
52-wk Low
$0.28

AHZ.AX

Chart for AHZ.AX

About

Admedus Limited is a healthcare company, which develops, commercializes and distributes medical technologies and devices. The Company is engaged in the sale and distribution of the infusion medical device and the ADAPT tissue portfolio with a particular focus in the area of cardiovascular Neonatal repair. The Company operates... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $93.00
Shares Outstanding(Mil.): 254.80
Dividend: --
Yield (%): --

Financials

  AHZ.AX Industry Sector
P/E (TTM): -- 33.72 30.38
EPS (TTM): -0.13 -- --
ROI: -86.80 13.18 14.86
ROE: -84.30 16.79 16.28

BRIEF-Admedus has received market approval for Cardiocel in United Arab Emirates

* Has received market approval for Cardiocel in United Arab Emirates Source text for Eikon: Further company coverage:

Nov 20 2016

BRIEF-Admedus receives clearance for Vascucel in U.S.

* Has received FDA 510(K) clearance to market Vascucel TM in US Source text for Eikon: Further company coverage:

Oct 16 2016

Earnings vs. Estimates